As of my last update in October 2023, there is limited publicly available information regarding the chemical substance ONO-7579, identified by the CAS number 1622212-25-2. ONO-7579 is a compound that has been investigated primarily in the context of pharmaceutical research, particularly for its potential therapeutic applications. It is known to be a selective inhibitor of certain biological pathways, which may contribute to its efficacy in treating specific diseases. The compound's molecular structure, solubility, stability, and pharmacokinetic properties are critical for understanding its behavior in biological systems. However, detailed characteristics such as its exact molecular formula, physical properties, and specific mechanisms of action may not be widely documented in public databases. For comprehensive and precise information, including safety data and regulatory status, consulting specialized scientific literature or databases is recommended.

ONO-7579

1622212-25-2: As of my last update in October 2023, there is limited publicly available information regarding the chemical substance ONO-7579, identified by the CAS number 1622212-25-2. ONO-7579 is a compound that has been investigated primarily in the context of pharmaceutical research, particularly for its potential therapeutic applications. It is known to be a selective inhibitor of certain biological pathways, which may contribute to its efficacy in treating specific diseases. The compound's molecular structure, solubility, stability, and pharmacokinetic properties are critical for understanding its behavior in biological systems. However, detailed characteristics such as its exact molecular formula, physical properties, and specific mechanisms of action may not be widely documented in public databases. For comprehensive and precise information, including safety data and regulatory status, consulting specialized scientific literature or databases is recommended.

<p>ONO-7579, an orally active TRKA inhibitor, effectively suppresses tumor growth by inhibiting TRKA phosphorylation. In KM12 colorectal cancer cells, it exhibits an EC 50 of 17.6 ng/g, indicating that a concentration of 17.6 ng per gram of tumor tissue reduces the activity of phosphorylated TRKA by 50%. This compound is utilized in cancer research.</p>

CAS 1622212-25-2

ONO-7579

ONO-7579

Ref: TM-T200301